Worldwide Gastrointestinal Industry to 2029 - Latest Innovations and Future Assessments - ResearchAndMarkets.com

·1 min read

DUBLIN, May 23, 2022--(BUSINESS WIRE)--The "Global Gastrointestinal Market, Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

This report focuses on the Gastrointestinal market revenue at the global, regional, and company levels. From a global perspective, this report represents overall Gastrointestinal market size by analyzing historical data and future prospects.

The review gives an inside and out the investigation of the worldwide gastrointestinal market with the latest innovations and future assessments to clarify unavoidable venture pockets.

Regionally, this report focuses on several key regions: North America, Europe, Asia Pacific, South America, the Middle East, and Africa.

Key Points Covered in the Report

  • Market Revenue of the Gastrointestinal Market from 2017 to 2029.

  • Market Forecast for the Gastrointestinal Market from 2021 to 2029.

  • Regional Market Share and revenue from 2017 to 2029.

  • Country Market share within the region from 2017 to 2029.

  • Key Drug Class and Route of Administration revenue and forecast.

  • Company Market Share Analysis, competitive scenario, ranking, and detailed company profiles.

  • Market driver, restraints, and detailed COVID-19 impact on Gastrointestinal Market.

Companies Mentioned

  • Takeda Pharmaceutical

  • Valeant Pharmaceuticals

  • Nestle

  • AstraZeneca

  • Bayer AG

  • Janssen CarePath

  • Abbott Laboratories

  • Boehringer Ingelheim

For more information about this report visit https://www.researchandmarkets.com/r/tur5l2

View source version on businesswire.com: https://www.businesswire.com/news/home/20220523005578/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting